OpenEvidence
For verified healthcare professionals, including physicians, who require NPI verification for access.
OpenEvidenceSnapshot
Who is OpenEvidence?
Equipping healthcare professionals with AI-powered clinical decision support grounded in peer-reviewed medical literature.
Target audience
Rivals analysis in progress
Portfolio
Free 1Last updated
OpenEvidence
v2.8.31
4mo ago
Publisher DNA
What defines OpenEvidence?
Publisher DNA
Primary focus
AI-powered clinical decision support
Scale
indie
Target audience
Verified healthcare professionals, including physicians, who require NPI verification for access.
Signature Patterns
- •Exclusive reliance on peer-reviewed literature and official journal partnerships for content grounding.
- •Gated access model requiring NPI verification to ensure a professional user base.
- •High-frequency update cadence focused on a single-product ecosystem.
- •Monetization strategy currently focused on a free-to-user model for verified professionals.
Portfolio momentum
Released 10 updates for its flagship app in the last 6 months, with the most recent major update occurring only 7 days ago.
Portfolio
What does OpenEvidence ship?
Apps
1 app analysed
Single-market publisher, every app ships only to United States.
Based on 1 of 1 app with localized market data · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
The Analyst's Read
The bottom line on OpenEvidence
Bottom line
OpenEvidence is a highly specialized medical publisher that has successfully leveraged institutional partnerships to build a high-trust moat in the clinical AI space. Their disciplined focus on a single, high-performing app suggests a strategy of deep integration within professional medical workflows.
Frequently asked questions
How many apps does OpenEvidence publish?
What kind of apps does OpenEvidence make?
What is OpenEvidence's top app?
In how many countries are OpenEvidence's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 0
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- yes